Image
Harm reduction strategies and tools should be accessible to everyone – regardless of location, time, and/or experience.
Harm reduction strategies and tools should be accessible to everyone – regardless of location, time, and/or experience.
This Advisory offers guidance to providers and administrators in SUD treatment programs on screening clients for hepatitis A, hepatitis B, and hepatitis C infections, as well as action steps for the treatment and support of clients with a viral hepatitis infection and a SUD.
This technical package, a collaborative effort between CDC and NASTAD, provides a broad framework as well as evidence-informed strategies and approaches to support the planning, design, implementation, and sustainability of new and existing syringe services programs (SSPs).